Skip to main content
Log in

Equilibrium and Kinetic Factors Influencing Bile Sequestrant Efficacy

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

In vitro bile salt binding equilibria and kinetic studies were performed with cholestyramine to determine how these factors influence bile sequestrant efficacy in vivo. Chloride ion at physiologic concentrations caused more than a twofold reduction in glycocholate (GCH) binding, compared to binding in the absence of salt, over a range of GCH concentrations and was also observed to displace bound GCH. In addition, chloride ion displaced from cholestyramine as a result of bile salt binding was measured using a chloride selective electrode, and the results show that bile salt binding is due to ion exchange. Comparison of the results of the equilibrium binding experiments to human data shows that the effect of anion binding competition alone cannot account for the lack of efficacy of cholestyramine. Consideration of other effects, such as additional binding competition or poor availability for binding, based on data from the literature, shows that adequate bile salt binding potential exists and that these interferences are not major factors influencing resin efficacy. In kinetic studies, both binding uptake of GCH and displacement of GCH from cholestyramine by chloride ion were relatively rapid, indicating that cholestyramine should equilibrate rapidly with bile salts in the GI tract. Based on these findings, it is suggested that the low efficacy of cholestyramine is a result mainly of its relatively poor ability to prevent bile salt reabsorption in the ileum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. T. A. Miettinen. Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects. J. Clin. Invest. 64:1485–1493 (1979).

    Google Scholar 

  2. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:365–374 (1984).

    Google Scholar 

  3. G. Oster and A. M. Epstein. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. JAMA 258:2381–2387 (1987).

    Google Scholar 

  4. R. De Simone, F. Conti, M. R. Lovati, M. Sirtori, E. Cocuzza, and C. R. Sirtori. New microporous cholestyramine analog for treatment of hypercholesterolemia. J. Pharm. Sci. 67:1695–1698 (1978).

    Google Scholar 

  5. H. Toda, K. Kihara, M. Hashimoto, and S. Mizogami. Bile acid binding and hypocholesterolemic activity of a new anion exchange resin from 2-methylimidizole and epichlorohydrin. J. Pharm. Sci. 77:531–533 (1988).

    Google Scholar 

  6. W. T. Beher, G. J. Lin, K. K. Casazza, and J. Bertasius. Effects of anion-exchange polymers on bile acid metabolism in the rat. Atherosclerosis 16:169–174 (1972).

    Google Scholar 

  7. W. H. Johns and T. R. Bates. Quantification of the binding tendencies of cholestyramine. I. Effect of structure and added electrolyte on the binding of unconjugated and conjugated bile-salt anions. J. Pharm. Sci. 58:179–183 (1969).

    Google Scholar 

  8. F. Helferrich. Ion Exchange, McGraw-Hill, New York, 1962.

    Google Scholar 

  9. S. Buadvari (ed.). The Merck Index, 11th ed., Merck & Co., Rahway, NJ, 1989, p. 342.

    Google Scholar 

  10. J. T. Garbutt and T. J. Kenney. Effect of cholestyramine on bile acid metabolism in normal man. J. Clin. Invest. 51:2781–2789 (1972).

    Google Scholar 

  11. M. C. Carey, M. J. Armstrong, N. A. Mazer, H. Igimi, and G. Salvioli. Measurement of the hydrophillic-hydrophobic balance of bile salts: Correlation with physical-chemical interactions between membrane lipids and bile salt micelles. In G. Paumgartner, A. Stiehl, and W. Gerok (eds.), Bile Acids and Cholesterol in Health and Disease, MTP Press, Lancaster, PA, 1983, pp. 31–42.

    Google Scholar 

  12. T. C. Northfield and I. McColl. Postprandial concentrations of free and conjugated bile acids from the length of the normal human small intestine. Gut 14:513–518 (1973).

    Google Scholar 

  13. G. E. Boyd, J. Schubert, and A. W. Adamson. The exchange adsorption of ions from aqueous solutions by organic zeolites. I. Ion-exchange equilibria. J. Am. Chem. Soc. 69:2818–2829 (1947).

    Google Scholar 

  14. J. S. Fordtran and T. W. Locklear. Ionic constituents and osmolality of gastric and small-intestinal fluids after eating. Am. J. Digest. Dis. 11:503–521 (1966).

    Google Scholar 

  15. C. Lentner (ed.). Geigy Scientific Tables, Ciba-Geigy Limited, Basle, 1981, p. 147.

    Google Scholar 

  16. L. M. Hagerman, D. A. Julow, and D. L. Schneider. In vitro binding of mixed micellar solutions of fatty acids and bile salts by cholestyramine. Proc. Soc. Exp. Biol. Med. 143:89–92 (1973).

    Google Scholar 

  17. R. Kos, J. L. White, S. L. Hem, and M. T. Borin. Effect of competing anions on binding of bile salts by cholestyramine. Pharm. Res. 8:238–241 (1991).

    Google Scholar 

  18. W. H. Johns and T. R. Bates. Quantification of the binding tendencies of cholestyramine. II. Mechanism of the interaction with bile salt and fatty acid salt anions. J. Pharm. Sci. 59:329–333 (1970).

    Google Scholar 

  19. A. F. Hofmann and B. Borgstrom. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc. 21:43–50 (1962).

    Google Scholar 

  20. A. F. Hofmann and B. Borgstrom. The intraluminal phase of fat digestion in man: The lipid content of the micellar and oil phases of intestinal contents. J. Clin. Invest. 43:247–257 (1964).

    Google Scholar 

  21. L. M. Hagerman and D. L. Schneider. Effect of cholestyramine on fecal bile salt excretion in rats fed diets containing mediumchain triglycerides or corn oil. Proc. Soc. Exp. Biol. Med. 143:93–96 (1973).

    Google Scholar 

  22. R. B. Zurier, S. A. Hashim, and T. B. Van Itallie. Effect of medium chain triglycerides on cholestyramine-induced steatorrhea in man. Gastroenterology 49:490–495 (1965).

    Google Scholar 

  23. G. W. Kuron, N. Grier, and J. W. Huff. The bile acid binding and hypercholesterolemic action of two water-soluble polymers. Atherosclerosis 37:353–360 (1980).

    Google Scholar 

  24. T. A. Miettinen. Mechanism of nonabsorbable lipid-lowering drugs. In Proc. Sixth Int. Congr. Pharmacol, Vol. 4, Finn. Pharmacol. Soc, Helsinki, 1975, pp. 149–158.

    Google Scholar 

  25. P. E. Luner. Ph.D. dissertation, University of Michigan, Ann Arbor, 1990, pp. 142–146.

  26. S. Lindenbaum and T. Higuchi. Binding of bile acids to cholestyramine at gastric pH conditions. J. Pharm. Sci. 64:1887–1889 (1975).

    Google Scholar 

  27. G. L. Starobinets and I. F. Gleim. Ion exchange of weak organic electrolytes. Russ. J. Phys. Chem. 39:1166–1169 (1965).

    Google Scholar 

  28. Y. Farag and J. G. Nairn. Rate of release of organic carboxylic acids from ion-exchange resins. J. Pharm. Sci. 77:872–875 (1988).

    Google Scholar 

  29. J. Blanchard and J. G. Nairn. The binding of cholate and glycocholate anions by anion-exchanging resins. J. Phys. Chem. 72:1204–1208 (1968).

    Google Scholar 

  30. S.-D. Clas. Cellulose ionomers as cholesterol-lowering drugs. Polym. Preprints 29:438–439 (1988).

    Google Scholar 

  31. W. H. Johns and T. R. Bates. Quantification of the binding tendencies of cholestyramine. III. Rates of adsorption of conjugated bile salt anions onto cholestyramine as a function of added inorganic electrolyte concentration, temperature, and agitation intensity. J. Pharm. Sci. 59:788–793 (1970).

    Google Scholar 

  32. A. Billiau and J. Van den Bosch. The influence of cholestyramine on the intestinal absorption of glycocholic acid. Arch. Int. Pharmacodyn. 150:46–51 (1964).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luner, P.E., Amidon, G.L. Equilibrium and Kinetic Factors Influencing Bile Sequestrant Efficacy. Pharm Res 9, 670–676 (1992). https://doi.org/10.1023/A:1015862329303

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015862329303

Navigation